Abstract We the report the case of a 28 years old female patients which referred to our Department in May 2005 for acute hepatitis and a history of relapsing neurologic deficits. Transverse myelitis was diagnosed and she was treated with corticosteroids obtaining progressive remission. Two months thereafter she complained a right sided visual loss. Optic neuritis was diagnosed and she was treated with corticosteroids again, obtaining a significant improvement. A diagnosis was made of autoimmune hepatitis (AIH) in a patient affected by neuromyelitis optica (NMO). She was treated with corticosteroids, IVIg and azathioprine, with progressive remission. No new flares of hepatic or neurologic disease were observed in the 2 years follow-up , except for residual visual deficit. NMO (also known as Devic’s syndrome) is a demyelinating disease whose distinction from multiple sclerosis (MS) has long been unclear, because NMO patients usually fulfill MS diagnostic criteria. The importance of separating NMO from MS is twofold: 1) NMO has a worse outcome but 2) responds to immunosuppressive therapy. NMO has been reported in association with a widespread group of immune-mediated diseases, including SLE, Sjogren’s syndrome, vasculitis and sarcoidosis. To date, this is the first description on NMO and AIH occurring in the same patient.

Devic's neuromyelitis optica and autoimmune hepatitis: first description of a new association / F.Fassio; F.Cappelli; I.Cecioni; R.Biagiotti; MG.Giudizi; F.Almerigogna. - In: ALLERGY. - ISSN 0105-4538. - STAMPA. - 63s88:(2008), pp. 355-355. (Intervento presentato al convegno 27th Congress of the European-Academy-of-Allergology-and-Clinical-Immunology tenutosi a Barcelona, SPAIN nel JUN 07-11, 2008).

Devic's neuromyelitis optica and autoimmune hepatitis: first description of a new association.

FASSIO, FILIPPO;CAPPELLI, FRANCESCA;CECIONI, ILARIA;BIAGIOTTI, ROBERTA;GIUDIZI, MARIA GRAZIA;ALMERIGOGNA, FABIO
2008

Abstract

Abstract We the report the case of a 28 years old female patients which referred to our Department in May 2005 for acute hepatitis and a history of relapsing neurologic deficits. Transverse myelitis was diagnosed and she was treated with corticosteroids obtaining progressive remission. Two months thereafter she complained a right sided visual loss. Optic neuritis was diagnosed and she was treated with corticosteroids again, obtaining a significant improvement. A diagnosis was made of autoimmune hepatitis (AIH) in a patient affected by neuromyelitis optica (NMO). She was treated with corticosteroids, IVIg and azathioprine, with progressive remission. No new flares of hepatic or neurologic disease were observed in the 2 years follow-up , except for residual visual deficit. NMO (also known as Devic’s syndrome) is a demyelinating disease whose distinction from multiple sclerosis (MS) has long been unclear, because NMO patients usually fulfill MS diagnostic criteria. The importance of separating NMO from MS is twofold: 1) NMO has a worse outcome but 2) responds to immunosuppressive therapy. NMO has been reported in association with a widespread group of immune-mediated diseases, including SLE, Sjogren’s syndrome, vasculitis and sarcoidosis. To date, this is the first description on NMO and AIH occurring in the same patient.
2008
27th Congress of the European-Academy-of-Allergology-and-Clinical-Immunology
Barcelona, SPAIN
JUN 07-11, 2008
F.Fassio; F.Cappelli; I.Cecioni; R.Biagiotti; MG.Giudizi; F.Almerigogna
File in questo prodotto:
File Dimensione Formato  
abstractBarc2008.pdf

Accesso chiuso

Tipologia: Versione finale referata (Postprint, Accepted manuscript)
Licenza: Tutti i diritti riservati
Dimensione 160.53 kB
Formato Adobe PDF
160.53 kB Adobe PDF   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/539857
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact